Concepedia

Laurence Colin

LC

22

Publications

1.1K

Citations

16

H-Index

1968

Active since

Affiliations

Novartis (United States)(Current)

Novartis (Switzerland)

Université Libre de Bruxelles

Novartis Institutes for BioMedical Research

Université de Strasbourg

Laurence Colin is an author at Novartis (United States) specializing in natural sciences, medicine, and engineering.

ORCID

Top concepts

Publications per year

1968–2020

22

Publications

22

Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4+ T cells from HIV-1-infected HAART-treated patients

Sophie Bouchat, Jean-Stéphane Gatot, Kabamba Kabeya et al. · AIDS · 2012 · 145 citations · Full text

Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin

Geremia B. Bolli, Francesco Dotta, Laurence Colin et al. · Diabetes Obesity and Metabolism · 2009 · 104 citations

A Novel Anti-CD40 Monoclonal Antibody, Iscalimab, for Control of Graves Hyperthyroidism—A Proof-of-Concept Trial

George J. Kahaly, Marius N. Stan, Lara Frommer et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 93 citations

First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody

Pascal Espié, Yanling He, Phillip J. Koo et al. · American Journal of Transplantation · 2019 · 81 citations

5-hydroxymethylcytosine marks promoters in colon that resist DNA hypermethylation in cancer

Santiago Uribe‐Lewis, Rory Stark, Thomas Carroll et al. · Genome Biology · 2015 · 80 citations · Full text

Rows per page

1–5 of 22